{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:05:01Z","timestamp":1789653901234,"version":"4.0.0"},"reference-count":32,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interstitial granulomatous dermatitis (IGD) is a rare inflammatory dermatosis with heterogeneous clinical presentations and a characteristic granulomatous histopathological pattern. Evidence\u2010based therapeutic recommendations are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To systematically review and synthesize the available evidence on therapeutic strategies for IGD, with emphasis on treatment effectiveness, disease resolution and relapse, and to propose a practice\u2010oriented management approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted according to PRISMA guidelines. PubMed\/MEDLINE was searched from inception to February 2026. Studies reporting treatment outcomes in patients with histologically confirmed IGD were included. Data on demographics, associated diseases, suspected drug triggers, treatments and clinical outcomes were extracted and analysed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 108 articles, comprising 182 patients, were included. They were 115 females (63.2%) with a median age of 58\u2009years. The most frequent presentation consisted of plaques, followed by a combination of plaques and papules localized on the axillae, groin and\/or the proximal portions of the limbs. Rheumatological or autoimmune diseases represented the most frequent association (in about 50% of patients). A drug\u2010induced aetiology was identified in 33.5% of cases (including cardiovascular drugs, biologic agents and targeted therapies), with drug withdrawal leading to complete or partial resolution in 95.9% of evaluable patients. Haematological and solid tumours were found in 18.4% of cases. Among treatments, topical corticosteroids achieved complete response in 52.2% of cases, while systemic corticosteroids resulted in complete response in 58.3%. Immunomodulatory agents (including hydroxychloroquine, methotrexate and dapsone) showed variable efficacy. TNF\u2010\u03b1 inhibitors and JAK inhibitors were associated with high response rates in refractory disease. Disease recurrence occurred in 27.0% of patients with available follow\u2010up data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Optimal management of IGD relies on an aetiology\u2010oriented approach. Withdrawal of causative drugs represents the most effective intervention when applicable. Topical and systemic corticosteroids remain first\u2010line therapies; immunomodulatory and biologic agents are reserved for refractory disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.70718","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:39:17Z","timestamp":1789652357000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-6921","authenticated-orcid":false,"given":"Francesco","family":"Bellinato","sequence":"first","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine University of Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4864-0940","authenticated-orcid":false,"given":"Sara","family":"Salvagno","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine University of Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Colato","sequence":"additional","affiliation":[{"name":"Section of Pathology, Department of Diagnostics and Public Health University of Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-9001","authenticated-orcid":false,"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine University of Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8548-0493","authenticated-orcid":false,"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine University of Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2015.03.005","article-title":"Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification","volume":"33","author":"Rosenbach M","year":"2015","journal-title":"Dermatologic Clinics"},{"key":"e_1_2_14_3_1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2133.2011.10727.x","article-title":"Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern","volume":"166","author":"Peroni A","year":"2012","journal-title":"The British Journal of Dermatology"},{"key":"e_1_2_14_4_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/11530080-000000000-00000","article-title":"Non\u2010infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence\u2010based update to important clinical questions","volume":"11","author":"Hawryluk EB","year":"2010","journal-title":"American Journal of Clinical Dermatology"},{"key":"e_1_2_14_5_1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jamadermatol.2013.256","article-title":"Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis","volume":"149","author":"Leloup P","year":"2013","journal-title":"JAMA Dermatology"},{"key":"e_1_2_14_6_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0560.1998.tb01693.x","article-title":"The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity","volume":"25","author":"Magro CM","year":"1998","journal-title":"Journal of Cutaneous Pathology"},{"issue":"6","key":"e_1_2_14_7_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14207","article-title":"Interstitial granulomatous dermatitis following tocilizumab, a paradoxical reaction?","volume":"33","author":"Altemir A","year":"2020","journal-title":"Dermatologic Therapy"},{"key":"e_1_2_14_8_1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000527461","article-title":"Underlying systemic diseases in interstitial granulomatous dermatitis and palisaded neutrophilic granulomatous dermatitis: a systematic review","volume":"239","author":"Yang C","year":"2023","journal-title":"Dermatology"},{"key":"e_1_2_14_9_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000372-199908000-00002","article-title":"Interstitial granulomatous dermatitis with plaques","volume":"21","author":"Aloi F","year":"1999","journal-title":"The American Journal of Dermatopathology"},{"key":"e_1_2_14_10_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/12034754231220937","article-title":"Reactive granulomatous dermatitis: a descriptive study of 10 patients","volume":"28","author":"Lagac\u00e9 M","year":"2024","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"8","key":"e_1_2_14_11_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2020.0594","article-title":"Interstitial granulomatous dermatitis associated with myelofibrosis","volume":"82","author":"Phillips D","year":"2021","journal-title":"British Journal of Hospital Medicine (London, England)"},{"issue":"2","key":"e_1_2_14_12_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D330263589","article-title":"The rope sign, a typical and yet infrequent clue","volume":"30","author":"Garcia\u2010Rodriguez V","year":"2024","journal-title":"Dermatology Online Journal"},{"key":"e_1_2_14_13_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-017-8666-8","article-title":"Cutaneous granulomatosis: a comprehensive review","volume":"54","author":"Terziroli Beretta\u2010Piccoli B","year":"2018","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"e_1_2_14_14_1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/cup.12704","article-title":"Cordoniform morphea: a clinicopathologic study of two cases presenting with the rope sign","volume":"43","author":"Tomasini C","year":"2016","journal-title":"Journal of Cutaneous Pathology"},{"issue":"3","key":"e_1_2_14_15_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/ajd.13888","article-title":"Two cases of granulomatous mycosis fungoides mimicking interstitial granulomatous dermatosis","volume":"63","author":"Stagg B","year":"2022","journal-title":"The Australasian Journal of Dermatology"},{"key":"e_1_2_14_16_1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/cup.13707","article-title":"Patch\u2010type granuloma annulare: an institution\u2010based study of 23 cases","volume":"47","author":"Khanna U","year":"2020","journal-title":"Journal of Cutaneous Pathology"},{"issue":"12","key":"e_1_2_14_17_1","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/jdv.18203","article-title":"Reactive granulomatous dermatitis as a clinically relevant and unifying term: a retrospective review of clinical features, associated systemic diseases, histopathology and treatment for a series of 65 patients at Mayo Clinic","volume":"36","author":"Bangalore Kumar A","year":"2022","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_14_18_1","first-page":"243","article-title":"Skin manifestations of rheumatoid arthritis","volume":"153","author":"Lora V","year":"2018","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"key":"e_1_2_14_19_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0961203315604908","article-title":"Interstitial granulomatous dermatitis associated with systemic lupus erythematosus: case report and review of the literature","volume":"25","author":"Jandali B","year":"2016","journal-title":"Lupus"},{"key":"e_1_2_14_20_1","article-title":"Interstitial granulomatous dermatitis as the initial manifestation of granulomatosis with polyangiitis","volume":"15","author":"Rimawi A","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"e_1_2_14_21_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5021\/ad.2017.29.3.337","article-title":"Interstitial granulomatous dermatitis in a patient with prostate cancer","volume":"29","author":"Kim SM","year":"2017","journal-title":"Annals of Dermatology"},{"key":"e_1_2_14_22_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archdermatol.2011.39","article-title":"Myelodysplastic syndrome presenting as generalized granulomatous dermatitis","volume":"147","author":"Balin SJ","year":"2011","journal-title":"Archives of Dermatology"},{"key":"e_1_2_14_23_1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1468-3083.2006.01982.x","article-title":"Interstitial granulomatous dermatitis associated with autoimmune hepatitis","volume":"21","author":"Lee KJ","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"e_1_2_14_24_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40257-020-00566-4","article-title":"Granulomatous cutaneous drug eruptions: a systematic review","volume":"22","author":"Shah N","year":"2021","journal-title":"American Journal of Clinical Dermatology"},{"key":"e_1_2_14_25_1","doi-asserted-by":"crossref","DOI":"10.5070\/D3257044810","article-title":"Interstitial granulomatous drug reaction related to hydrochlorothiazide","volume":"25","author":"Grose E","year":"2019","journal-title":"Dermatology Online Journal"},{"issue":"1","key":"e_1_2_14_26_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0560.2010.01518.x","article-title":"Drug\u2010associated reversible granulomatous T cell dyscrasia: a distinct subset of the interstitial granulomatous drug reaction","volume":"37","author":"Magro CM","year":"2010","journal-title":"Journal of Cutaneous Pathology"},{"key":"e_1_2_14_27_1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/DAD.0b013e3181af21b6","article-title":"Interstitial granulomatous drug reaction to adalimumab","volume":"32","author":"Martorell\u2010Calatayud A","year":"2010","journal-title":"The American Journal of Dermatopathology"},{"key":"e_1_2_14_28_1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000372-200108000-00003","article-title":"Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis","volume":"23","author":"Perrin C","year":"2001","journal-title":"The American Journal of Dermatopathology"},{"issue":"3","key":"e_1_2_14_29_1","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1303a129","article-title":"Interstitial granulomatous dermatitis and palisaded neutrophilic granulomatous dermatitis: retrospective Clinicopathological analysis of 16 cases","volume":"13","author":"Sar\u0131kaya Tellal E","year":"2023","journal-title":"Dermatology Practical & Conceptual"},{"key":"e_1_2_14_30_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/kel264","article-title":"Clinical vignette: interstitial granulomatous dermatitis (Ackerman's syndrome) in SLE presenting with the rope sign","volume":"46","author":"Dubey S","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_14_31_1","first-page":"30","article-title":"Interstitial granulomatous dermatitis associated with chronic inflammatory demyelinating polyneuropathy","volume":"90","author":"Walling HW","year":"2012","journal-title":"Cutis"},{"key":"e_1_2_14_32_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1468-3083.2006.01826.x","article-title":"Infliximab therapy for interstitial granulomatous dermatitis","volume":"21","author":"Kreuter A","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_14_33_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.12659\/AJCR.890074","article-title":"Interstitial granulomatous dermatitis successfully treated with etanercept","volume":"15","author":"Ahmed ZS","year":"2014","journal-title":"Am. J. Case Rep"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70718","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70718","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:39:21Z","timestamp":1789652361000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":32,"alternative-id":["10.1111\/jdv.70718"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70718","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"2026-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdv.70718"}}